The effects of menopause and age on calcitropic hormones: A cross‐sectional study of 655 healthy women aged 35 to 90

Journal of Bone and Mineral Research

Volumn 10, Issue 6, 1995, Pages 835-842

  Prince, Richard L ^a,b   Dick, Ian ^a   Devine, Amanda ^a   Price, Roger I ^b   Gutteridge, Donald H ^b   Kerr, Deborah ^a   Criddle, Arthur ^a   Garcia‐Webb, Peter ^b   John, Andrew St ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CREATINE; HYDROXYPROLINE; VITAMIN D;

ADULT; AGED; AGING; ARTICLE; BONE MASS; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; HUMAN; HUMAN EXPERIMENT; MENOPAUSE AND CLIMACTERIUM; NORMAL HUMAN; OSSIFICATION; PROTEIN BINDING; VITAMIN DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALKALINE PHOSPHATASE; BONE DEVELOPMENT; BONE RESORPTION; CALCITRIOL; CALCIUM; COHORT STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN; HYDROXYPROLINE; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGE; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONES; PHOSPHORUS; POSTMENOPAUSE; SERUM ALBUMIN; SUPPORT, NON-U.S. GOV'T; VITAMIN D-BINDING PROTEIN;

EID: 0029047904     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.5650100602     Document Type: Article

References (57)

1. The relative contributions of age and years since menopause to postmenopausal bone loss.
2. Estrogen binding, receptor mRNA, and biologic response in osteoblast‐like osteosarcoma cells.
3. Evidence of estrogen receptors in normal human osteoblast‐like cells.
4. Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McClune‐Albright Syndrome).
5. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
6. Effects of estrogen on circulating “free” and total 1.25‐dihydroxyvitamin D and on the parathyroid‐vitamin D axis in postmenopausal women.
7. Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women.
8. Impaired vitamin D metabolism with aging in women.
9. Deficient production of 1,25‐dihydroxyvitamin D in elderly osteoporotic patients.
10. Effects of natural and artificial menopause on plasma and urinary calcium and phosphorus.
11. Evidence for a renal calcium leak in postmenopausal women.
12. Prevention of postmenopausal osteoporosis: A comparative study of exercise, calcium supplementation, and hormone‐replacement therapy.
13. Fracture prevalence in an Australian population.
14. Determinants of intestinal calcium absorption in women ten years past the menopause.
15. Assay of circulating 1,25‐dihydroxyvitamin D involving a novel single‐cartridge extraction and purification procedure.
16. Comparison of the performance and clinical utility of a carboxy‐terminal assay and an intact assay for parathyroid hormone.
17. Chromatography of serum on Sep‐pak C18 corrects falsely elevated vitamin D metabolite levels measured by protein binding assay.
18. The measurement of the vitamin D‐binding protein in human serum.
19. Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25‐hydroxyvitamin D, 1,25‐dihydroxyvitamin D, or vitamin D‐binding protein.
20. Changes in vitamin D metabolism during natural and medical menopause.
21. The effects of the menopause on calcitriol and parathyroid hormone: Responses to a low dietary calcium stress test.
22. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25‐dihydroxyvitamin D, and parathyroid hormone in postmenopausal women.
23. Relationship between plasma calcium fractions, other bone‐related variables, and serum follicle‐stimulating hormone levels in premenopausal, perimenopausal, and postmenopausal women.
24. Effect of menopause and aging on serum total and ionized calcium and protein concentrations.
25. The effects of menopause and estrogen replacement therapy on the renal handling of calcium.
26. Direct modulation by estradiol of the response of human bone cells (SaOS‐2) to human parathyroid hormone (PTH) and PTH‐related protein.
27. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin‐growth factor‐1, and parathyroid hormone‐stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones.
28. Identification of estrogen receptor mRNA and the estrogen modulation of parathyroid hormone‐stimulated cyclic AMP accumulation in opossum kidney cells.
29. The influence of age on bone mineral regulating hormones.
30. Interrelationship among Vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: Evidence of an age‐related intestinal resistance to 1,25‐dihydroxyvitamin D action.
31. 2 in elderly subjects.
32. Low 1,25‐Dihydroxyvitamin D, secondary hyperparathyroidism, and normal osteocalcin in elderly subjects.
33. Influence of Vitamin D on parathyroid function in the elderly.
34. Serum levels of vitamin D metabolites in the elderly.
35. Testosterone secretion and metabolism in male senescence.
36. Calcitriol deficiency with retained synthetic reserve in chronic renal failure.
37. Determinants of intact parathyroid hormone and free 1,25‐dihydroxyvitamin D levels in mild and moderate renal failure.
38. Metabolic inactivation of Vitamin D is enhanced in primary hyperparathyroidism.
39. Vitamin D and femoral neck fractures in elderly South Australian women.
40. Age‐related changes in bone density, serum parathyroid hormone, calcium absorption and other indices of bone metabolism in Chinese women.
41. 3 synthesis in human skin.
42. Oral intake of phosphorus can determine the serum concentration of 1,25‐dihydroxyvitamin D by determining its production rate in humans.
43. Effects of aluminum hydroxide on the parathyroid‐vitamin D axis of postmenopausal women.
44. The regulation of calcitriol by parathyroid hormone and absorbed dietary phosphorus in subjects with moderate chronic renal failure.
45. Vitamin D status and related parameters in a healthy population: The effects of age, sex, and season.
46. Effect of age on variables relating to calcium and phosphorus metabolism in women.
47. The effect of age, sex and other factors on blood chemistry in health.
48. Patterns of change for various biochemical constituents detected in well population screening.
49. The relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin and blood urea.
50. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects.
51. Effect of age on serum immunoreactive parathyroid hormone and its biological effects.
52. Increases in immunoreactive parathyroid hormone with age.
53. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells.
54. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.
55. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
56. Effect of calcium supplementation on bone loss in postmenopausal women.
57. 3 and calcium to prevent hip fractures in elderly women.